Market By Product Type, Application, End-user And Geography | Forecast 2019-2028
An analysis by Triton Market Research has concluded that the European protein expression market will expand at a CAGR of 10.75% during the forthcoming years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the Europe protein expression market are:
• Italy
• The United Kingdom
• Germany
• Russia
• France
• Spain
• Rest of Europe
The protein expression market in Europe is witnessing growth due to the rising disposable income of the consumers and easily accessible protein structure database. The growing geriatric population is more prone to chronic diseases, thereby fueling the demand for this market in the region. Moreover, the presence of major contract research organizations that facilitate the research activities of protein expression and its further application in antibody & vaccine production is also contributing to the growth of the regional market.
Europe has a well-developed healthcare infrastructure, and a great emphasis on proteomics and genomics R&D activities is experienced in countries like Switzerland, France, the United Kingdom and Germany. This has fueled the growth of the studied market in the coming years.
The United Kingdom is considered as an important country in terms of research & development activities. There is a high rate of adoption of new technology in healthcare in the UK, as compared to other countries in the region. The country is making huge investments in this sector and is expected to grow even further. These factors are consequently leading to the development of the protein expression market in the country.
Lonza is a company providing products & services to the healthcare, pharmaceutical and life sciences industries. The company provides custom development and production of drugs and drug delivery systems and anti-microbial solutions. It has two major business operational segments, pharma & biotech and specialty ingredients. The specialty ingredients segment focuses on the development and marketing of anti-microbial applications, covering hygiene, preservatives, capsules & food supplements and nutrition & personal care products.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   EUROPE PROTEIN EXPRESSION MARKET - SUMMARY       Â
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONÂ Â Â Â Â
2.2. KEY INSIGHTSÂ Â Â Â Â Â
2.2.1.  THERAPEUTIC APPLICATIONS HOLDS THE LARGEST SHAREÂ
2.3. PORTER’S FIVE FORCE ANALYSIS  Â
2.3.1.  THREAT OF NEW ENTRANTS  Â
2.3.2.  THREAT OF SUBSTITUTE          Â
2.3.3.  BARGAINING POWER OF SUPPLIERS
2.3.4.  BARGAINING POWER OF BUYERS    Â
2.3.5.  THREAT OF COMPETITIVE RIVALRY Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.6.1.  GROWING PREVALENCE OF CHRONIC DISEASES
2.6.2.  RISE IN HEALTHCARE EXPENDITURE         Â
2.6.3.  INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS
2.7. MARKET RESTRAINTSÂ Â
2.7.1.  HIGH COST OF PROTEIN EXPRESSION SYSTEMS
2.7.2.  STRINGENT REGULATORY APPROVAL       Â
2.8. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.8.1.  RISE IN PHARMACEUTICAL MARKET IN EMERGING REGIONSÂ
2.9. MARKET CHALLENGES
2.9.1.  LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS  Â
2.10. IMPACT OF COVID-19 ON PROTEIN EXPRESSION MARKETÂ Â Â
3.   EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY PRODUCT TYPE     Â
3.1. REAGENTS
3.2. EXPRESSION VECTORSÂ Â Â Â Â Â Â Â Â Â Â
3.3. COMPETENT CELLSÂ Â Â Â Â Â
3.4. INSTRUMENTSÂ Â Â Â
3.5. SERVICESÂ
4.   EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY APPLICATION
4.1. THERAPEUTICÂ Â Â Â Â
4.2. INDUSTRIALÂ Â Â Â Â Â Â Â Â
4.3. RESEARCHÂ Â Â Â Â Â Â Â Â Â
5.   EUROPE PROTEIN EXPRESSION MARKET OUTLOOK - BY END-USER   Â
5.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIESÂ Â Â
5.2. ACADEMIC RESEARCH INSTITUTES
5.3. CONTRACT RESEARCH ORGANIZATIONSÂ
5.4. OTHER END-USERSÂ Â Â Â Â Â
6.   EUROPE PROTEIN EXPRESSION MARKET – REGIONAL OUTLOOK          Â
6.1. UNITED KINGDOMÂ Â Â Â Â Â Â Â Â Â
6.2. GERMANYÂ
6.3. FRANCEÂ Â Â Â
6.4. SPAINÂ Â Â Â Â Â Â Â Â
6.5. ITALYÂ Â Â Â Â Â Â Â Â Â
6.6. RUSSIAÂ Â Â Â Â Â
6.7. REST OF EUROPEÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
7.   COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGIES INC
7.2. BD (BECTON, DICKINSON AND COMPANY)
7.3. BIO-RAD LABORATORIES INC
7.4. GENSCRIPTÂ Â Â Â Â Â Â Â Â Â
7.5. LIFESENSORS
7.6. MERCK KGAAÂ Â Â Â Â Â Â
7.7. PROMEGA CORPORATIONÂ Â Â Â Â Â
7.8. QIAGENÂ
7.9. TAKARA HOLDINGS INC
7.10. THERMO FISHER SCIENTIFIC INC
7.11. LONZAÂ Â Â Â Â Â
7.12. NEW ENGLAND BIOLABSÂ Â Â Â Â Â Â
7.13. BIOTECHRABBITÂ Â Â Â Â Â Â Â Â Â Â
7.14. PROMABÂ Â
7.15. PEAK PROTEINS LTD
8.   METHODOLOGY & SCOPE Â
8.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
8.2. SOURCES OF DATAÂ Â Â Â Â Â Â
8.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: EUROPE PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: EUROPE PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: MARKET ATTRACTIVENESS INDEX
FIGURE 4: EUROPE PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 5: EUROPE PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)
FIGURE 6: EUROPE PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)
FIGURE 7: EUROPE PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)
FIGURE 11: EUROPE PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)
FIGURE 12: EUROPE PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)
FIGURE 15: EUROPE PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 16: EUROPE PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 17: UNITED KINGDOM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 18: GERMANY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 19: FRANCE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 20: SPAIN PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 21: ITALY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 22: RUSSIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: REST OF EUROPE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)